Bright Minds Biosciences Financial Statements 2020-2025 | DRUG

Revenue

Cost Of Goods Sold

Gross Profit

Research And Development Expenses

$0.867

$3.708

$9.537

$4.998

SG&A Expenses

$0.588

$1.153

$0.884

$0.939

$1.957

Other Operating Income Or Expenses

$-0.62

$-0.617

$-1.303

$-1.018

Operating Expenses

Operating Income

$-2.075

$-5.477

$-11.724

$-6.954

$-1.957

Total Non-Operating Income/Expense

$0.015

$0.011

$0.01

$0.107

Pre-Tax Income

$-2.059

$-5.467

$-11.716

$-6.847

Income Taxes

Income After Taxes

$-2.059

$-5.467

$-11.716

$-6.847

Other Income

Income From Continuous Operations

$-2.059

$-5.467

$-11.716

$-6.847

Income From Discontinued Operations

Net Income

$-2.059

$-5.467

$-11.716

$-6.847

EBITDA

$-2.021

$-5.423

$-11.719

$-6.954

$-1.957

EBIT

$-2.075

$-5.477

$-11.724

$-6.954

$-1.957

Basic Shares Outstanding

Shares Outstanding

Basic EPS

$-0.48

$-1.47

$-4.74

$-3.81

EPS - Earnings Per Share

$-0.48

$-1.47

$-4.74

$-3.81